Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Blood test predicts immunotherapy benefit early among patients with advanced lung cancer

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy. This finding has the potential to facilitate early treatment decisions,…

Blood test predicts immunotherapy benefit early among patients with advanced lung cancer

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Monday 3 August →